-
Budget Impact Analysis of Ondansetron Oral Dissolving Film vs. Oral Solution in the Chemotherapy-Induced Nausea and Vomiting for Egyptian Pediatric Patients
Sep 9, 2025, 16:22 PM -
Bigger, Better Studies: Prioritizing Literature Review Using an Approach Based on Large Language Models
Sep 9, 2025, 16:22 PM -
Increased Functional Impairment Associated With Generalized Anxiety Disorder (GAD): Findings From a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Shortage of Antineoplastics and Supportive Medicines in Armenia
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile
Sep 9, 2025, 16:22 PM -
Indirect Costs Associated With Pneumococcal Disease: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Comparing Key European HTA Body Methodological Standards for Systematic Reviews of Economic and Utility Evidence
Sep 9, 2025, 16:22 PM -
The Key Role of Social Participation in Health Technology Assessment: Experiences From South American Countries
Sep 9, 2025, 16:22 PM -
Reframing Pharmaceutical Pricing: Implications of the 2025 SVR Report for Germany’s Pricing Logic and International Spillovers
Sep 9, 2025, 16:22 PM -
Danicopan in Addition to the Component 5 Inhibitor C5i Ravulizumab for the Treatment of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Residual Hemolytic Anemia in Greece: A Cost Utility Analysis
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM -
Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial
Sep 9, 2025, 16:22 PM -
Accelerating RTOR in Oncology: The AIM Model for Agile Trial Operations
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema
Sep 9, 2025, 16:22 PM -
Social Media Listening Analysis of Cannabis Use in Patients With Inflammatory Bowel Disease
Sep 9, 2025, 16:22 PM -
A Critical Review of the Screening Criteria Ratings and Recommendations by the UK National Screening Committee (NSC) for 30 Adult Conditions
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Systematic Reviews: An Investigation Into the Impact of Eligible Studies Being Excluded by Artificial Intelligence
Sep 9, 2025, 16:22 PM -
Current Use of Hereditary Angioedema (HAE) Treatments in Sweden: An Analysis of the National Prescribed Drug Register
Sep 9, 2025, 16:22 PM -
Facilitator-Led vs. Remote Components Within Structured Expert Elicitation of Survival Outcomes: A Targeted Review
Sep 9, 2025, 16:22 PM
